For research use only. Not for therapeutic Use.
Tamnorzatinib(CAT: I016672) is an orally bioavailable, small-molecule tyrosine kinase inhibitor (TKI) under investigation for its anticancer potential. It selectively targets dysregulated kinase signaling pathways that drive tumor cell proliferation, survival, and metastasis. Preclinical studies suggest Tamnorzatinib’s utility in inhibiting oncogenic signaling cascades, making it a valuable tool for cancer research and drug development. Its activity profile supports exploration in solid tumors and hematologic malignancies where kinase-driven pathways are critical. Researchers employ Tamnorzatinib to probe molecular mechanisms of kinase inhibition and to advance therapeutic strategies in oncology, particularly within targeted cancer therapy and precision medicine applications.
| CAS Number | 1646839-59-9 |
| Synonyms | N-[5-(6,7-dimethoxyquinolin-4-yl)oxypyridin-2-yl]-2,5-dioxo-1-phenyl-7,8-dihydro-6H-quinoline-3-carboxamide |
| Molecular Formula | C32H26N4O6 |
| Purity | ≥95% |
| IUPAC Name | N-[5-(6,7-dimethoxyquinolin-4-yl)oxypyridin-2-yl]-2,5-dioxo-1-phenyl-7,8-dihydro-6H-quinoline-3-carboxamide |
| InChI | InChI=1S/C32H26N4O6/c1-40-28-16-21-24(17-29(28)41-2)33-14-13-27(21)42-20-11-12-30(34-18-20)35-31(38)23-15-22-25(9-6-10-26(22)37)36(32(23)39)19-7-4-3-5-8-19/h3-5,7-8,11-18H,6,9-10H2,1-2H3,(H,34,35,38) |
| InChIKey | WHMMKPWGWNYYFE-UHFFFAOYSA-N |
| SMILES | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CN=C(C=C3)NC(=O)C4=CC5=C(CCCC5=O)N(C4=O)C6=CC=CC=C6 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
